Rationale of an economically driven PD1 biomarker development in lung cancer—an academic dilemma
Crossref DOI link: https://doi.org/10.1007/s12254-016-0281-5
Published Online: 2016-08-29
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hilbe, Wolfgang
Bartsch, Rupert
Zielinski, Christoph
License valid from 2016-08-29